CLN5 and Atrophy: The global and regional brain volume changes assessed by structural MRI in the current study show a general trend towards attenuation of atrophy in CLN5‐affected sheep that received moderate‐dose scAAV9/oCLN5 gene therapy at a pre‐symptomatic disease stage; however, the majority of measurements were not normalized to healthy control volumes.